Compare
2 stocks, side by sideRelative performance · rebased to 100
ALNYONC
Pair ratio · ALNY ÷ ONCRelative value, rich or cheap vs their own history
The price ratio ALNY ÷ ONC with its 1Y mean and ±1σ / ±2σ bands; the z-score is how far the ratio sits from its average. A stretched reading flags one stock as rich vs the other relative to their history, but mean-reversion isn't guaranteed (a durable re-rating from better growth or margins can keep the ratio elevated). Research tooling, not advice.
| ALNYAlnylam Pharmaceuticals, Inc. | ONCBeOne Medicines AG | |
|---|---|---|
| Smart Score | 8/10 | 8/10 |
| Price | $293.17 | $275.34 |
| 1 month | -0.79% | -9.0% |
| 1 year | -9.8% | +3.2% |
| 5 year | +70% | -16% |
| P/E (TTM) | 67.8 | 50.9 |
| P/E vs sector | +115% | +62% |
| Market cap | $39.1B | $28.6B |
| Sector | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.